NewcelX (formerly NLS Pharma) — Post-IPO Debt
NewcelX (formerly NLS Pharma) raised $25.0M in a Post-IPO Debt round. View investors, financials, and press on Fsome.
Round Details
- Funded Company
- NewcelX (formerly NLS Pharma)
- Round Type
- Post-IPO Debt
- Amount Raised
- $25.0M
- Announced
- March 31, 2025
Canonical: https://fsome.com/funding/newcelx-formerly-nls-pharma-post-ipo-debt-6108414 · For the full investor list, press references, and related rounds, please enable JavaScript.